NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The UK manufacturing sector’s struggles showed signs of easing in July as confidence improved and output stabilized, according to a closely watched survey.Read More